The World Health Organization yesterday rejected the use Hydroxychloroquine, lopinavir/ritonavir drugs for the treatment of the pandemic corona virus and stated that it has henceforth discontinued the use of these drugs as it failed the result of the interim trial which showed that the drugs produced little or no reduction in mortality of hospitalized covid-19 patients when compared to standard of care.

The World Health Org. stated that The International Steering Committee formulated the recommendation in light of the evidence for hydroxychloroquine vs standard-of-care and for lopinavir/ritonavir vs standard-of-care from the Solidarity trial interim results, and from a review of the evidence from all trials presented at the 1-2 July, WHO Summit on COVID-19 research and innovation saying, it has “accepted the recommendation” from the International Steering Committee to discontinue the trial for hydroxychloroquine, as well as HIV/AIDS medications lopinavir and ritonavir, because they failed to reduce COVID-19 mortality.

The WHO also confirmed a new record of 212,326 new cases of the viral infection worldwide
https://dambela.com/2020/07/06/who-rejects-hydroxychloroquine-lopinavir-ritonavir-for-treatment-of-covid-19/

One step forward, two steps backwards.